By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Akonni Biosystems is seeking to raise $8 million, it disclosed in a document filed on Monday with the US Securities and Exchange Commission.

In its filing, the Frederick, Md.-based firm said it has raised $912,598 in the private round of financing so far. It did not say how the funds will be used but said the offering is not being made in connection with a merger, acquisition or exchange offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.